ANTI-CTLA4 CONJUGATES

Number of patents in Portfolio can not be more than 2000

United States of America

SERIAL NO

17596828

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to an anti-CTLA4 conjugate or a pharmaceutically acceptable salt thereof, wherein said conjugate comprises a plurality of anti-CTLA4 moieties -D covalently conjugated via at least one moiety -L1-L2- to a polymeric moiety Z, wherein -L1- is covalently and reversibly conjugated to -D and -L2- is covalently conjugated to Z and wherein -L1- is a linker moiety and -L2- is a chemical bond or a spacer moiety; and related aspects.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ASCENDIS PHARMA ONCOLOGY DIVISION A/STUBORG BOULEVARD 12 HELLERUP 2900

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
KITYK, Roman Heidelberg, DE 1 0
KNAPPE, Thomas Heidelberg, DE 15 44
LAUFER, Burkhardt Heidelberg, DE 15 54
NOWAK, Sarah Heidelberg, DE 1 0
STARK, Sebastian Heidelberg, DE 21 38
ZYDZIAK, Nicolas Heidelberg, DE 2 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation